Xiaoping HE

Assistant General Patent Counsel Asia and Australia Region IP Counsel

Eli Lilly and Company

Personal Profile


Dr. He has been engaged in pharmaceutical innovation IP work for more than 18 years in Japan. Prior to joining Eli Lilly Japan, she served as a global IP responsible manager for multiple biologics’ projects at Tokyo headquarters of Astellas Pharmaceuticals. In 2014, she was invited by Japan Institute of Promoting Invention and Innovation (JIII) to write and publish a patent practice monograph of more than 200,000 words comparing the differences between Chinese and Japanese biological and chemical patent protection practices. Dr. He obtained a Bachelor of Clinical Medicine and a Master of Pharmacology in China and a Ph.D. of bioscience in Japan.